Normoftal
Also known as Eye Peptide Bioregulator, Retina Peptide, AKS-G Peptide
Synthesized Khavinson peptide bioregulator containing short peptides (2-4 amino acids) derived from retinal tissue. 1,500 patients treated from 1995-2010 with 95% showing improved visual functions.
Regulatory Pathway
Dosing Protocol
Typical Dose
20-40 mg daily (therapy); 20 mg daily (prevention)
Frequency
1-2x daily, before meals
Duration
30-day courses, repeat after 2-6 months
Timing & Administration
Administer via Oral capsules, before meals. Frequency: 1-2x daily, before meals.
Popular Uses
Mechanism of Action
Reduces peptide deficiency and restores protein synthesis in retinal cells. Contains peptide AKS-G (lysine, glutamic acid). Provides neuroprotective effects through modulation of gene expression and protein synthesis.
Research Summary
Evidence level: clinical trials. Clinical status: Approved in Russia - Clinical use for retinal support.
Side Effects & Safety
Important Warnings
- Should not replace standard eye treatments
References
No references available.
Related Peptides
Browse all →A synthetic peptide derived from tuftsin, an immunomodulatory peptide. Approved in Russia for anxiety and nootropic effects.
View profileSynthetic peptide derived from ACTH (4-10) fragment with added Pro-Gly-Pro sequence. Used clinically in Russia for stroke, traumatic brain injury, and cognitive disorders.
View profileA neuropeptide mixture derived from porcine brain tissue, indicated for neurological conditions including stroke recovery, cognitive decline, and traumatic brain injury.
View profile